Natco Pharma’s US partner gets FDA nod for wakefulness tablets NEW DELHI: Natco Pharma’s marketing partner in US, Breckenridge Pharmaceutical Inc, has received a tentative approval from the US health regulator for its generic Armodafinil tablets used for improving wakefulness in adults. Breckenridge Pharmaceutical Inc has received tentative approval from the United States Food and Drug Administration (USFDA) for Armodafinil ... Read More »

BioReliance launches advanced in-vitro ADME and toxicology services designed to improve drug safety and efficacy BioReliance, Sigma-Aldrich Corporation’s biologics and early-development services business under SAFC Commercial, has introduced select in vitro ADME (absorption, distribution, metabolism and excretion) and toxicology testing services for pharmaceutical, chemical and industrial consumer products to its service offering. The broad set of highly predictive assays use ... Read More »

Pharma patent regime may get stricter, say experts In order to boost dollar inflows in pharma sector and establish stronger IPR regime, govt may affect patent amendments The joint statement issued on September 30 by the US and India to establish an annual high-level Intellectual Property (IP) working group has inevitably led to a debate on whether the governmentwould bow ... Read More »

New data on the global economic impact and burden of preventable blindness and vision impairment To highlight the critical need for access to eye care and regular eye examinations, Novartis and its eye care division, Alcon, are introducing new data on World Sight Day, highlighting the economic impact and burden that blindness and vision impairment can have on societies and ... Read More »

Aurobindo Pharma becomes fifth most valuable pharma firm Aurobindo Pharma has surged 21% in the past one week, making it the fifth-most valuable Indian pharma company behind Sun Pharmaceutical Industries, Lupin, Dr Reddy’s Laboratories and Cipla. The rally has seen Aurobindo surpass Ranbaxy Laboratories, Cadila Healthcare, Divi’s Laboratories, GlaxoSmithKline Pharmaceuticals, Glenmark Pharmaceuticals, Ipca Laboratories, Torrent Pharma, Biocon and Sanofi India ... Read More »

Schott Glass India wins environmental excellence award Schott’s pharmaceutical tubing unit in Gujarat recently won the excellence award in the green manufacturing units category of the VNM TV’s prestigious environmental excellence awards competition. This recognition identifies Schott’s pursuits in contributing to sustainable growth. In order to win the competition, Schott’s pharmaceutical tubing unit showcased all its activities that are carried ... Read More »

MedImmune and Cancer Research UK establish joint CRUK-MEDI Alliance Laboratory AstraZeneca today announced that MedImmune, its global biologics research and development arm, and Cancer Research UK, with its commercial arm, Cancer Research Technology (CRT), have entered into an innovative collaboration to establish a joint laboratory in Cambridge, UK. The new laboratory, representing a first of its kind partnership for both ... Read More »

Sun Pharma’s coming of age moment The Indian pharma major’s deal to Merck to acquire and market a plaque psoriasis drug is a bold move Sun Pharmaceuticals needs to be complimented. Not for the rate of its successful acquisitions but for attempting to do something that no Indian company has done before. Indian pharmaceutical companies are known globally for their ... Read More »

Petro, farm products drag export growth in Aug to 2.35% NEW DELHI, SEPT 15: India’s exports growth slowed down further to 2.35 per cent in August 2014 to $26.95 billion. The export numbers were at $ 26.33 billion in August 2013. Imports grew at 2.08 per cent during August 2014 to $37.79 billion compared to $ 37.02 billion in August ... Read More »

Sun Pharma shares dip 4% on ‘surprise’ USFDA inspection news COIMBATORE, SEPT 11:   Shares of Sun Pharmaceutical Industries ended with a loss of more than 4 per cent on Thursday on reports that its Halol manufacturing plant in Gujarat was subjected to surprise inspection by the American drug regulator United States Food and Drug Administration. The stock, which touched a ... Read More »